153 related articles for article (PubMed ID: 17196047)
1. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.
Lambert M; Schimmelmann BG; Naber D; Schacht A; Karow A; Wagner T; Czekalla J
J Clin Psychiatry; 2006 Nov; 67(11):1690-7. PubMed ID: 17196047
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
[TBL] [Abstract][Full Text] [Related]
3. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
[TBL] [Abstract][Full Text] [Related]
4. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
Novick D; Haro JM; Suarez D; Vieta E; Naber D
Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
[TBL] [Abstract][Full Text] [Related]
5. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to second generation antipsychotics in drug naïve patients with schizophrenia: a 1 year follow-up study in Shanghai.
Zhang HX; Shen XL; Zhou H; Yang XM; Wang HF; Jiang KD
Psychiatry Res; 2014 Jan; 215(1):20-5. PubMed ID: 24230993
[TBL] [Abstract][Full Text] [Related]
7. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.
Buckley PF; Harvey PD; Bowie CR; Loebel A
Schizophr Res; 2007 Aug; 94(1-3):99-106. PubMed ID: 17499480
[TBL] [Abstract][Full Text] [Related]
8. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.
Karow A; Moritz S; Lambert M; Schöttle D; Naber D;
Eur Psychiatry; 2012 Aug; 27(6):401-5. PubMed ID: 21570262
[TBL] [Abstract][Full Text] [Related]
9. Remission in the outpatient care of schizophrenia: 3-year results from the Schizophrenia Outpatients Health Outcomes (SOHO) study in France.
Gasquet I; Haro JM; Tcherny-Lessenot S; Chartier F; Lépine JP
Eur Psychiatry; 2008 Oct; 23(7):491-6. PubMed ID: 18573640
[TBL] [Abstract][Full Text] [Related]
10. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics].
Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP
Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420
[TBL] [Abstract][Full Text] [Related]
11. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
J Clin Psychiatry; 2004 Nov; 65(11):1525-30. PubMed ID: 15554767
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
13. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride.
Lambert M; Naber D; Eich FX; Schacht M; Linden M; Schimmelmann BG
Acta Psychiatr Scand; 2007 Feb; 115(2):106-13. PubMed ID: 17244174
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
Prikryl R; Kholova M; Kucerova HP; Ceskova E
Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
16. [Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years].
Haro JM; Ciudad A; Alonso J; Bousoño M; Suárez D; Novick D; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(4):187-96. PubMed ID: 18461495
[TBL] [Abstract][Full Text] [Related]
17. Remission as perceived by people with schizophrenia, family members and psychiatrists.
Karow A; Naber D; Lambert M; Moritz S;
Eur Psychiatry; 2012 Aug; 27(6):426-31. PubMed ID: 21571506
[TBL] [Abstract][Full Text] [Related]
18. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
19. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
Stahl SM; Malla A; Newcomer JW; Potkin SG; Weiden PJ; Harvey PD; Loebel A; Watsky E; Siu CO; Romano S
J Clin Psychopharmacol; 2010 Aug; 30(4):425-30. PubMed ID: 20571437
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?
Haro JM; Novick D; Perrin E; Bertsch J; Knapp M
Psychiatry Res; 2014 Dec; 220(1-2):163-9. PubMed ID: 25194449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
